# SCM earnings call intelligence LOPJLB CallCard / temporal rollup · freemium · [stock page](https://www.lopjlb.com/stock/SCM) · [Earnings tab](https://www.lopjlb.com/stock/SCM?tab=earnings) Updated: 2026-08-10T09:07:11 Quarters analyzed: 8 ## Cross-quarter narrative Across eight quarterly calls Stellus Capital’s portfolio expanded from roughly $900 million in mid‑2024 to just above $1 billion by late‑2025, reflecting steady asset accumulation despite a slowing pipeline and tariff‑related M&A headwinds. Net investment income per share fell from $0.39 in 2024 Q3 to $0.29 in 2025 Q4 and $0.32 in 2025 Q3, eroding dividend coverage and prompting repeated commentary on dividend sustainability. Spread compression emerged early, moving from high‑6% ranges to low‑5% and later stabilising around 5% over SOFR, limiting margin expansion. Management repeatedly flagged tariff risk and government policy uncertainty in 2024 Q4 and 2025 Q1, but those concerns faded as the focus shifted to execution of a pending Ridgepost adviser partnership and the pending third SBIC license. Non‑accrual loans rose from 2.9% of loan cost in 2024 Q2 to over 9% of cost by 2026 Q1, heightening credit‑risk worries. Capital actions evolved from ATM share issuances in 2024‑2025 to a $20 million buyback announcement in 2025 Q4 and a broader share‑repurchase program in 2026 Q1, though execution delays were noted. Overall, growth in assets contrasts with deteriorating earnings, margin pressure, and heightened credit and dividend risks. ## Latest CallCard · Q1 Stellus reports stable Q1 asset quality, modest earnings, a pending Ridgepost partnership and SBIC license, while noting dividend pressure and elevated nonaccrual loans. **Guidance:** maintained — Guidance unchanged; expects Q2 portfolio near $970M with repayments roughly matching new fundings and continued realizations. **Tone:** mgmt 0.7 · Q&A pressure 0.5 · divergence 0.2 Prepared remarks highlighted capacity to increase the portfolio by $75‑100M, a new Ridgepost partnership and a $20M share buyback as value‑creating opportunities. ### Demand visibility Management sees a stable pipeline with upside from Ridgepost and a pending SBIC license. Pipeline growth is expected in the back half of the year post‑Ridgepost tie‑up; spreads are stabilizing around 5% over SOFR, and nonaccrual resolution is targeted for year‑end. ### Margins / costs Spreads have stabilized around 5% over SOFR with no material widening. Management noted competitive pressures keep spreads in the high‑4% to mid‑5% range, providing steady but limited margin expansion. ### Capital allocation Announced a $20M share buyback (not yet executed) and plans to recycle equity gains and resolved nonaccruals to grow the portfolio. Capital will be allocated to increase the investment base by $75‑100M, leveraging a new SBIC license and the Ridgepost partnership, while the buyback awaits a longer repurchase window. ### Milestones - **Ridgepost Capital platform integration** [new]: External adviser joining this summer, expected to unlock hundreds of millions in new lending opportunities. - **Third SBIC license** [at_risk]: Anticipated award this summer; would enable $75‑100M portfolio expansion. - **Share repurchase program** [new]: Up to $20M authorized; no repurchases in Q1 due to timing constraints. - **Portfolio capacity increase** [on_track]: Targeting $75‑100M growth via recycling equity gains and new licensing. - **Nonaccrual loan reduction** [at_risk]: Progress expected toward end of year; 12‑24 month horizon for resolution. - **Regulatory leverage management** [on_track]: Regulatory leverage around 1x (2x with SBA), providing balance‑sheet flexibility. ### Fears / risks - **Dividend sustainability**: Dividend may be lowered as net investment income growth stalls. - **Nonaccrual loan levels**: Elevated nonaccruals (9.2% of cost) could pressure earnings and asset quality. - **Spread compression**: Stabilized spreads around 5% limit margin expansion if they do not widen. - **Dependence on private‑equity sponsors**: Recovery of nonaccruals relies on sponsor capital support, which may wane. - **Ridgepost partnership execution**: Growth benefits contingent on successful integration of the adviser platform. - **SBIC license uncertainty**: Portfolio growth targets depend on timely approval of the third SBIC license. - **Competitive market environment**: Intense competition keeps spreads tight, affecting profitability. - **Regulatory leverage constraints**: While regulatory leverage is low, borrowing base limits could restrict future scaling. ### Key quotes > “We added one new loan to our nonaccrual list during the quarter.” > “our expectation is that the dividend will be coming down associated with that.” > “We did not repurchase any shares after the previous quarter end.” — Robert Ladd > “our average deal we're looking at today is approximately a 5% spread over SOFR” ## Quarter one-liners - **2026 Q1:** Stellus reports stable Q1 asset quality, modest earnings, a pending Ridgepost partnership and SBIC license, while noting dividend pressure and elevated nonaccrual loans. - **2025 Q4:** SCM Q4 2025: Portfolio stable at ~$1B, NII $0.29/share, dividend maintained at $0.34/share, advisor sale to Ridge Post Capital pending, $20M buyback authorized, software exposure limited to 6.8% of loan portfolio.','tone': {'mgmt - **2025 Q3:** SCM Q3: NII $0.32, NAV -$0.16; portfolio >$1B, 82% rated 1/2; credit facility extended, spreads tightening; expect Q4 equity realizations $5M, dividend $0.40.','tone': {'mgmt': 0.3, 'mgmt_rationale': 'Management highlighted portfolio growth to >$1B, asset quality slightly better than plan, active or - **2025 Q2:** — - **2025 Q1:** Q1 saw $0.35 GAAP NII per share, dividend $0.40 declared, portfolio at $991M, new ATM share issuance above NAV, and management expects flat Q2 activity amid slower pipeline. - **2024 Q4:** Stellus Capital posted Q4 2024 GAAP net investment income of $0.35 per share, grew its portfolio to $953.5 M, announced a $0.40 dividend, highlighted a strong pipeline, low leverage and noted tariff and spread‑compression risks. - **2024 Q3:** SCM Q3 NII $0.39/sh, core $0.40/sh; portfolio $909M; guides Q4 portfolio $930-950M; spreads compressing from 6s to 5s; non-accruals 4.7%; ATM active, facility upsized to $315M; dividend $0.40/qtr. maintained. Spillover $42M. Fee waiver possible Q2 2025. Active pipeline 10-15 deals. Equity realizatio - **2024 Q2:** SCM Q2: NII covers dividend, portfolio grows to $900M, guidance for Q3 $920-940M, ATM raises $25M above NAV, 5 nonaccruals at 2.9%, leverage below target, dividend maintained at $0.40.','tone':{'mgmt':0.4,'mgmt_rationale':'Management highlighted active pipeline, portfolio growth expectations, divide ## Theme arcs - **Portfolio size** (improving): Grew from $900M to >$1B - **Net investment income per share** (deteriorating): Declined from $0.39 to $0.29 - **Dividend sustainability** (deteriorating): Dividend cut to $0.34 in 2025 Q4 - **Spread compression** (stable): Compressed to low‑5% and later stabilised around 5% - **Tariff risk** (resolved): Prominent in 2024 Q4/2025 Q1, absent later - **Pipeline activity** (deteriorating): Slowed in 2025 Q1 due to tariff‑related M&A slowdown - **Regulatory/license acquisition** (new): Third SBIC license pursued, still pending - **Non‑accrual loan levels** (deteriorating): Rising to 9.2% of loan cost by 2026 Q1 - **Capital actions** (new): ATM issuance completed, buyback announced, share‑repurchase program launched - **Partnership integration** (new): Ridgepost adviser platform pending integration ## Fear persistence - **Tariff risk** [resolved]: Highlighted in 2024 Q4/2025 Q1, not mentioned later - **Spread compression** [recurring]: Consistently noted from 2024 Q3 through 2026 Q1 - **Dividend sustainability** [recurring]: Raised in 2024 Q4, intensified in 2025 Q1 and 2026 Q1 ## Guidance path 2024 Q2:vague → 2024 Q3:vague → 2024 Q4:maintained → 2025 Q1:maintained → 2025 Q2:vague → 2025 Q3:vague → 2025 Q4:vague → 2026 Q1:maintained --- Research context only. Not personalized investment advice. API: `GET /bff/api/bigfive/earnings-intel/SCM`